Previous studies using human cancer cell lines and canine melanoma cell lines have shown that inhibition of XPO1 with SINE compounds can result in a compensatory upregulation of XPO1 mRNA as a result of XPO1 protein loss.28, 34. The gene discussed is XPO1; the disease is melanoma.